Alaunos Therapeutics, Inc.

The momentum for this stock is not very good. Alaunos Therapeutics, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Alaunos Therapeutics, Inc..
Log in to see more information.

News

TCRT Stock Earnings: Alaunos Therapeutics Reported Results for Q2 2024
TCRT Stock Earnings: Alaunos Therapeutics Reported Results for Q2 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nAlaunos Therapeutics just reported results for the second quarter of 2024.\nThe post TCRT Stock Earnings: Alaunos Therapeutics Reported...\n more…

Alaunos Therapeutics (NASDAQ:TCRT) Trading Down 4.2%
Alaunos Therapeutics (NASDAQ:TCRT) Trading Down 4.2%

Ticker Report Alaunos Therapeutics, Inc. (NASDAQ:TCRT - Get Free Report) fell 4.2% on Tuesday . The company traded as low as $2.42 and last traded at $2.44. 12,364 shares changed hands during trading, a decline of...\n more…

TCRT Stock Earnings: Alaunos Therapeutics Reported Results for Q1 2024
TCRT Stock Earnings: Alaunos Therapeutics Reported Results for Q1 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nAlaunos Therapeutics just reported results for the first quarter of 2024.\nThe post TCRT Stock Earnings: Alaunos Therapeutics Reported...\n more…

TCRT Stock Earnings: Alaunos Therapeutics Misses EPS for Q4 2023
TCRT Stock Earnings: Alaunos Therapeutics Misses EPS for Q4 2023

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nTCRT stock results show that Alaunos Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.\nThe post...\n more…

Comparing Alaunos Therapeutics (NASDAQ:TCRT) and Homology Medicines (NASDAQ:FIXX)
Comparing Alaunos Therapeutics (NASDAQ:TCRT) and Homology Medicines (NASDAQ:FIXX)

Ticker Report Alaunos Therapeutics (NASDAQ:TCRT Get Free Report) and Homology Medicines (NASDAQ:FIXX Get Free Report) are both small-cap medical companies, but which is the superior stock? We will...\n more…

Short Interest in Alaunos Therapeutics, Inc. (NASDAQ:TCRT) Decreases By 7.1%
Short Interest in Alaunos Therapeutics, Inc. (NASDAQ:TCRT) Decreases By 7.1%

Zolmax Alaunos Therapeutics, Inc. (NASDAQ:TCRT Get Free Report) was the recipient of a large decrease in short interest in January. As of January 31st, there was short interest totalling 1,710,000...\n more…